NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹1,154 Cr | ₹1,096 Cr | ₹919 Cr | ₹808 Cr | ₹790 Cr |
What is the latest Total Expenditure of NEULAND LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹1,154 Cr |
| Mar2024 | ₹1,096 Cr |
| Mar2023 | ₹919 Cr |
| Mar2022 | ₹808 Cr |
| Mar2021 | ₹790 Cr |
How is Total Expenditure of NEULAND LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,154 Cr | 5.25 | |
| Mar2024 | ₹1,096 Cr | 19.21 | |
| Mar2023 | ₹919 Cr | 13.72 | |
| Mar2022 | ₹808 Cr | 2.32 | |
| Mar2021 | ₹790 Cr | - | |
Compare Total Expenditure of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹17,423.1 Cr | -3.3% | -13.5% | -3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -3.3% |
-13.5% |
-3.5% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses